InvestSMART

Vitasora Health Limited (ASX: VHL) - Share Price

Current share price for VHL : $0.014 0.001 (6.67%)+

Vitasora Health Limited (VHL, formerly Respiri Limited), an ASX-listed company, is an international e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US remote patient monitoring market. Its technology detects wheeze, a typical symptom of Asthma, COPD and respiratory disease to provide an objective measure of airway limitation. Vitasora Health created technology optimises how patients in partnership with their physicians manage chronic respiratory conditions.

VHL General Information +

ASX Code VHL
Website http://www.vitasorahealth.com.au
Industry/Sector Health Care Equipment
Market Cap ($M) 32
VHL Share Price $0.014
Day High $0.016
Day Low $0.014
Last Close $0.015
VHL Share Price Movement $0.00 ( 6.67% )
Prices as at 16:35, 22 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Vitasora Health Limited (VHL) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Vitasora Health Limited (VHL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Vitasora Health Limited (VHL) price-sensitive announcements

VHL - VHL Raises $4m Cornerstoned by $3m Strategic Investment
Vitasora Health Limited announced it has raised $4.0 million through a successful share pl
Vitasora Health Limited (VHL)
11 Jun 2026 | 9:24 AM
VHL - Trading Halt
On 9 June 2026, Vitasora Health Limited (ASX: VHL) requested a trading halt on its securit
Vitasora Health Limited (VHL)
9 Jun 2026 | 8:43 AM
VHL - Vitasora Execute vCare Rollout - Revenue Scaling Accelerates
Vitasora Health Limited announced the successful implementation of its vCare Electronic Me
Vitasora Health Limited (VHL)
18 May 2026 | 9:29 AM
VHL - Quarterly Activities/Appendix 4C Cash Flow Report
For the quarter ended 31 March 2026, Vitasora Health Limited reported a 24% increase in th
Vitasora Health Limited (VHL)
30 Apr 2026 | 10:00 AM

Vitasora Health Limited (VHL) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
 Health Care $33 Notification of cessation of securities - VHL 22 Jun 2026 1:44PM $0.015 $0.014 fallen by 6.67%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
 Health Care $33 Cleansing Notice 18 Jun 2026 9:25AM $0.018 $0.014 fallen by 22.22%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
 Health Care $33 Application for quotation of securities - VHL 18 Jun 2026 9:23AM $0.018 $0.014 fallen by 22.22%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
 Health Care $33 Investor Presentation 11 Jun 2026 9:56AM $0.011 $0.014 risen by 33.33%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
 Health Care $33 Proposed issue of securities - VHL 11 Jun 2026 9:24AM $0.011 $0.014 risen by 33.33%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
 Health Care $33 Proposed issue of securities - VHL 11 Jun 2026 9:24AM $0.011 $0.014 risen by 33.33%

VHL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$10.11 -$0.70 -1.40% 0.00 0.00 0.00% 0.0%
2024A -$7.44 -$0.70 1.40% 0.00 0.00 0.00% 0.0%
2023A -$5.78 -$0.70 -20.90% 0.00 0.00 0.00% 0.0%

VHL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Cochlear Limited (COH) $7,474M 0.0171 -0.1883 0.0862 19.0983 23.5286 21.6622 3.76% 3.03% 3.24%
Fisher & Paykel Healthcare Corporation Limited (FPH) $18,729M 0.1388 0.1365 0.1883 48.2232 42.4295 35.7071 1.36% 1.46% 1.65%
ResMed Inc. (RMD) $15,136M 0.3087 9.7634 0.0805 182.2558 16.9329 15.6712 1.26% 1.33% 1.40%
Vitasora Health Limited (VHL) $42M -0.0137 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

VHL Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.61 0.00
Market 0.29 13.20 1.17 0.67
Sector 0.57 22.30 1.64 2.71

VHL Directors

Name Position Start Date
Mr Nicholas Smedley Executive Chairman, Executive Director 30 Oct 2019
Mr Marjan Mikel Executive Director, Chief Executive Officer, Managing Director 25 Nov 2019
Mr Jonathan Adams Non-Executive Director 24 Feb 2025

Vitasora Health Limited (VHL) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
1 Oct 2025 MIKEL, Marjan Issued Direct Shares 1,333,333 $0.030 $39,999.990
1 Oct 2025 MIKEL, Marjan Issued Indirect Shares 2,000,000 $0.030 $60,000.000
1 Oct 2025 SMEDLEY, Nicholas Issued Indirect Shares 3,333,333 $0.030 $99,999.990

See all changes in directors' interest & trades for Vitasora Health Limited (VHL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

VHL Management

Name Position
Peter Hildebrandt Chief Operating Officer
Samaneh Sarraf Shirazi Chief Research Officer
Tony Di Pietro Company Secretary

VHL Calendar of Events

Date Event
26 February 2027 Report (Interim)
27 August 2026 Report (Annual)
27 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.